ACAMPROSATE Side Effects

6444620-1 | Catatonia
on Nov 17, 2009 Female patient from GERMANY , 54 years of age, was diagnosed with major depression and was treated with Acamprosate (View Usage). Patient experienced the following unwanted or unexpected effects: catatonia. Acamprosate dosage: 1332 Milligram - Stopped. During the same period patient was treated with CITALOPRAM (20 Milligram) (View Citalopram Review and Citalopram Label ), CYAMEMAZINE (20 Milligram - Stopped) (View Cyamemazine Review and Cyamemazine Label ), DIPOTASSIUM (100 Milligram) (View Dipotassium Review and Dipotassium Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), CLORAZEPATE DIPOTASSIUM (View Clorazepate Dipotassium Review and Clorazepate Dipotassium Label ), THIAMINE (View Thiamine Review and Thiamine Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ). Patient was hospitalized.

5724838-3 | Myalgia
Patient was taking Acamprosate (View Usage). Patient had the following side effects: myalgia on Apr 30, 2008 from UNITED STATES Additional patient health information: Male patient , 46 years of age, . Acamprosate dosage: 666 Mg Hs Po.

5352072-8 | Alcoholic Liver Disease, Diarrhoea, Jaundice
Adverse event was reported on May 22, 2007 by a Female patient taking Acamprosate (View Usage) (Dosage: 666 Tid Po) was diagnosed with alcoholism (What is alcoholism?) and. Location: FRANCE , 40 years of age, After Acamprosate was administered, patient had the following side effects: alcoholic liver disease, diarrhoea, jaundice (What is jaundice?). During the same period patient was treated with NICOTINE (View Nicotine Review and Nicotine Label ), THIAMINE (View Thiamine Review and Thiamine Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN B CONCENTRATES (View Vitamin B Concentrates Review and Vitamin B Concentrates Label ). Patient was hospitalized.

5320917-3 | Aggression, Mood Swings
on Apr 24, 2007 Male patient from FRANCE , 44 years of age, was diagnosed with alcohol problem and was treated with Acamprosate (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, mood swings. Acamprosate dosage: . During the same period patient was treated with CHLORDIAZEPOXIDE (View Chlordiazepoxide Review and Chlordiazepoxide Label ), THIAMINE (View Thiamine Review and Thiamine Label ).


5157906-8 | Completed Suicide
on Oct 31, 2006 Female patient from UNITED STATES , 39 years of age, was treated with Acamprosate (View Usage). Patient had the following side effects: completed suicide. Acamprosate dosage: . During the same period patient was treated with ETHANOL (View Ethanol Review and Ethanol Label ).

4594114-3 | Diabetes Mellitus, Intentional Misuse, Metabolic Acidosis, Schizophrenia, Sedation, Somnolence, Suicide Attempt
Patient was taking Acamprosate (View Usage). After Acamprosate was administered, patient had the following side effects: diabetes mellitus, intentional misuse, metabolic acidosis, schizophrenia, sedation, somnolence, suicide attempt on Feb 03, 2005 from Additional patient health information: Male patient , 25 years of age, was diagnosed with overdose, diabetes mellitus and. Acamprosate dosage: 7992 Mg Once Po. During the same period patient was treated with METFORMIN (8000 Mg Once Po) (View Metformin Review and Metformin Label ), ZOPICLONE (60 Mg Once Po) (View Zopiclone Review and Zopiclone Label ), SULPRID (SULPIRIDE) (6400 Mg Once Po) (View Sulprid (sulpiride) Review and Sulprid (sulpiride) Label ), VENLAFAXINE HCL (600 Mg Once Po) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized.